Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at whether Mirtazapine was added to the on-going pharmacotherapy with risperidone in the mirtazapine group can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This observational study is following people with Early phase psychosis, Mental and Behavioural Disorders, or Schizophrenia to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at whether a digital support tool can help people with Mental health/schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Current information as of 10/12/09: Patients will have 12 one-hour group therapy sessions with a psychologist can help people with Psychic disorders, schizophrenia and other psychosis, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in Current information as of 10/12/09: Patients will have 12 one-hour group therapy sessions with a psychologist and complete follow-up assessments.
This study is looking at whether There is a 14-day screening period and a 3 to 7-day placebo washout period before randomisation of the participants for the trial can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether This is an intention to treat, repeated measure within subjects randomised trial can help people with Schizophrenia, co-morbid drug and alcohol dependence, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether psychoeducation can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in psychoeducation and complete follow-up assessments.
This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether psychoeducation can help people with Prodromal schizophrenia, Mental and Behavioural Disorders, or Schizotypal disorder. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia or Mental and Behavioural Disorders. Some participants may receive sham treatment instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether psychoeducation can help people with Schizophrenia or schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia, schizotypal and delusional disorders. Participants take part in psychoeducation and complete follow-up assessments.
This study is looking at whether Experimental intervention: MetaCognitive skill Training (MCT) focusing on delusion-relevant metacognitive biases in schizophrenia can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Experimental intervention: MetaCognitive skill Training (MCT) focusing on delusion-relevant metacognitive biases in schizophrenia and complete follow-up assessments.
This study is looking at whether Cognitive Behavioural Treatment versus Supportive Therapy can help people with psychosis or Mental and Behavioural Disorders. Participants take part in Cognitive Behavioural Treatment versus Supportive Therapy and complete follow-up assessments.
This study is looking at care and outcomes for people with Schizophrenia, Psychosis, Mental and Behavioural Disorders, or Schizophrenia. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
This study is looking at whether [A] Cognitive Behavioural Case Management [B] Treatment-as-usual can help people with Mental and Behavioural Disorders: Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in [A] Cognitive Behavioural Case Management [B] Treatment-as-usual and complete follow-up assessments.
This study is looking at whether Relapse prevention programme as opposed to treatment as usual can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Relapse prevention programme as opposed to treatment as usual and complete follow-up assessments.
This study is looking at whether The trial has three arms can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in The trial has three arms and complete follow-up assessments.
This study is looking at care and outcomes for people with Schizophrenia or Mental and Behavioural Disorders. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether Cognitive remediation therapy versus usual care can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Cognitive remediation therapy versus usual care and complete follow-up assessments.
This study is looking at whether Reasoning and rehabilitation programme versus treatment as usual can help people with Schizophrenia or schizoaffective disorder or Mental and Behavioural Disorders. Participants take part in Reasoning and rehabilitation programme versus treatment as usual and complete follow-up assessments.
This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia or Mental and Behavioural Disorders. Taking part may give some people access to 80 schizophrenia patients are randomly assigned to either risperidone (4 mg) or aripiprazole (15 mg), but direct benefit is not guaranteed.